期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 105, 期 1, 页码 167-175出版社
WILEY-LISS
DOI: 10.1002/jcb.21809
关键词
Raf-1; PAK5; ERK; mitochondria; kinase; phosphorylation
资金
- American Cancer Society [RSG-01-193-01-TBE]
- NIH [5R01CA116356-02]
- NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER
Raf-1 is an important effector of Ras mediated signaling and is a critical regulator of the ERK/MAPK pathway. Raf-1 activation is controlled in part by phosphorylation on multiple residues, including an obligate phosphorylation site at serine 338. Previously PAK1 and casein kinase II have been implicated as serine 338 kinases. To identify novel kinases that phosphorylate this site, we tested the ability of group II PAKs(PAKs 4-6) to control serine 338 phosphorylation. We observed that all group II PAKs were efficient serine 338 kinases, although only PAK1 and PAK5 significantly stimulated Raf-1 kinase activity. We also showed that PAK5 forms a tight complex with Raf-1 in the cell, but not A-Raf or B-Raf. Importantly, we also demonstrated that the association of Raf-1 with PAK5 targets a subpopulation of Raf-1 to mitochondria. These data indicate that PAK5 is a potent regulator of Raf-1 activity and may control Raf-1 dependent signaling at mitochondria.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据